Capdevila J, Falck J
J Lipid Res. 2018; 59(11):2047-2062.
PMID: 30154230
PMC: 6210905.
DOI: 10.1194/jlr.R087882.
Kodani S, Hammock B
Drug Metab Dispos. 2015; 43(5):788-802.
PMID: 25762541
PMC: 4407705.
DOI: 10.1124/dmd.115.063339.
Lamounier-Zepter V, Look C, Schunck W, Schlottmann I, Woischwill C, Bornstein S
Int J Obes (Lond). 2014; 39(5):755-61.
PMID: 25370574
DOI: 10.1038/ijo.2014.193.
Ulu A, Lee K, Miyabe C, Yang J, Hammock B, Dong H
J Cardiovasc Pharmacol. 2014; 64(1):87-99.
PMID: 24691274
PMC: 4092041.
DOI: 10.1097/FJC.0000000000000094.
Bukhari I, Shah A, Gauthier K, Walsh K, Koduru S, Imig J
Am J Physiol Heart Circ Physiol. 2012; 302(8):H1574-83.
PMID: 22307677
PMC: 3330801.
DOI: 10.1152/ajpheart.01122.2011.
Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats.
Jiang H, Quilley J, Doumad A, Zhu A, Falck J, Hammock B
Am J Physiol Heart Circ Physiol. 2011; 300(6):H1990-6.
PMID: 21398593
PMC: 3119086.
DOI: 10.1152/ajpheart.01267.2010.
Interaction of arachidonic acid with electrogenic properties of mouse chemosensory neurons.
Mazzatenta A, Di Giulio C, Pokorski M
Eur J Med Res. 2010; 15 Suppl 2:79-82.
PMID: 21147627
PMC: 4360362.
DOI: 10.1186/2047-783x-15-s2-79.
Vascular pharmacology of epoxyeicosatrienoic acids.
Pfister S, Gauthier K, Campbell W
Adv Pharmacol. 2010; 60:27-59.
PMID: 21081214
PMC: 3373307.
DOI: 10.1016/B978-0-12-385061-4.00002-7.
14,15-Dihydroxy-eicosa-5(Z)-enoic acid selectively inhibits 14,15-epoxyeicosatrienoic acid-induced relaxations in bovine coronary arteries.
Bukhari I, Gauthier K, Jagadeesh S, Sangras B, Falck J, Campbell W
J Pharmacol Exp Ther. 2010; 336(1):47-55.
PMID: 20881018
PMC: 3014297.
DOI: 10.1124/jpet.110.169797.
Epoxyeicosatrienoic acids and endothelium-dependent responses.
Campbell W, Fleming I
Pflugers Arch. 2010; 459(6):881-95.
PMID: 20224870
PMC: 3373596.
DOI: 10.1007/s00424-010-0804-6.
Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo.
Liu J, Park S, Morisseau C, Hwang S, Hammock B, Weiss R
Mol Cancer Ther. 2009; 8(8):2193-203.
PMID: 19671760
PMC: 2728155.
DOI: 10.1158/1535-7163.MCT-09-0119.
Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation.
Liu J, Tsai H, Hwang S, Jones P, Morisseau C, Hammock B
Br J Pharmacol. 2009; 156(2):284-96.
PMID: 19154430
PMC: 2697843.
DOI: 10.1111/j.1476-5381.2008.00009.x.
Role of CYP epoxygenases in A2A AR-mediated relaxation using A2A AR-null and wild-type mice.
Nayeem M, Poloyac S, Falck J, Zeldin D, Ledent C, Ponnoth D
Am J Physiol Heart Circ Physiol. 2008; 295(5):H2068-78.
PMID: 18805895
PMC: 2614586.
DOI: 10.1152/ajpheart.01333.2007.
Transcriptional regulation of the human soluble epoxide hydrolase gene EPHX2.
Tanaka H, Kamita S, Wolf N, Harris T, Wu Z, Morisseau C
Biochim Biophys Acta. 2007; 1779(1):17-27.
PMID: 18078836
PMC: 2699939.
DOI: 10.1016/j.bbagrm.2007.11.005.
Epoxyeicosatrienoic acids affect electrolyte transport in renal tubular epithelial cells: dependence on cyclooxygenase and cell polarity.
Nusing R, Schweer H, Fleming I, Zeldin D, Wegmann M
Am J Physiol Renal Physiol. 2007; 293(1):F288-98.
PMID: 17494091
PMC: 2077090.
DOI: 10.1152/ajprenal.00171.2006.
Epoxygenase metabolites. Epithelial and vascular actions.
Imig J
Mol Biotechnol. 2001; 16(3):233-51.
PMID: 11252808
DOI: 10.1385/MB:16:3:233.
Epoxidation of olefins by cytochrome P450: evidence from site-specific mutagenesis for hydroperoxo-iron as an electrophilic oxidant.
Vaz A, McGinnity D, Coon M
Proc Natl Acad Sci U S A. 1998; 95(7):3555-60.
PMID: 9520404
PMC: 19874.
DOI: 10.1073/pnas.95.7.3555.
Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cells.
Xiao Y, Huang L, Morgan J
J Physiol. 1998; 508 ( Pt 3):777-92.
PMID: 9518732
PMC: 2230927.
DOI: 10.1111/j.1469-7793.1998.777bp.x.
Conversion of glyceryl trinitrate to nitric oxide in tolerant and non-tolerant smooth muscle and endothelial cells.
Salvemini D, Pistelli A, Vane J
Br J Pharmacol. 1993; 108(1):162-9.
PMID: 8381319
PMC: 1907715.
DOI: 10.1111/j.1476-5381.1993.tb13457.x.
Effect of phenobarbitone pretreatment upon endothelium-dependent relaxation to acetylcholine in rat superior mesenteric arterial bed.
Randall M, Hiley C
Br J Pharmacol. 1988; 94(3):977-83.
PMID: 3179621
PMC: 1854023.
DOI: 10.1111/j.1476-5381.1988.tb11612.x.